The overall intent of the Outreach and Promotion Core is to provide integrated scientific, educational, administrative, and financial support for outreach efforts, training, and pilot projects related to the West Coast Central Comprehensive Metabolomics Resource Core (WC^MRC) mission. The Core will incorporates highly successful aspects of the UC Davis Clinical and Translational Science Center (CTSC) programs including the Research Education, Training, and Career Development Program, the Pilot Translational and Clinical Studies Program, and the Translational Technologies, Methodologies, and Resources Program that have been developed and thoroughly tested during 6 years of NIH funding. Offerings through the CTSC Education Program will be supplemented with new translational metabolomics core courses, seminars, and workshops that will provide crucial exposure of a spectrum of trainees to the metabolomics field. Examples for such workshops offered through this core will be Glycobiology and the Microbiome, Cancer Metabolism, Lipid Metabolism in Cardiovascular Diseases and Metabolic Pathways in Animal Models. Examples for specific metabolomic training courses are Metabolomics Basics, Advanced Metabolomics and Genomics in Metabolic Diseases, to be inclusive for all trainees in the WC^MRC with hands-on training experience opportunities. Importantly, the Core will engage regional and local scientists to participate in pilot and feasibility project programs. These programs aim to spark innovative and collaborative scientific endeavors by supporting and facilitating robust new research paradigms, technologies, and tools, and through partnerships that enhance team science. The basic principles in executing the pilot program include: (1) a requirement for submissions to represent new multidisciplinary teams;(2) the inclusion of trainees and exposure of these trainees to the WC^MRC and CTSC educational offerings;(3) active solicitation of partnerships and leveraging of funds from other UC Davis pilot programs;and (4) linking program announcements to translational workshops.
Studying and understanding metabolism in a comprehensive way is important to fight metabolic diseases, including diabetes, heart attacks, strokes, and cancer. Educating the next generation of scientist who can use modern tools in metabolic analysis lays the foundation for breakthroughs in understanding and treating metabolic diseases.
|Barkal, Layla J; Theberge, Ashleigh B; Guo, Chun-Jun et al. (2016) Microbial metabolomics in open microscale platforms. Nat Commun 7:10610|
|Cajka, Tomas; Fiehn, Oliver (2016) Toward Merging Untargeted and Targeted Methods in Mass Spectrometry-Based Metabolomics and Lipidomics. Anal Chem 88:524-45|
|Shih, P B; Yang, J; Morisseau, C et al. (2016) Dysregulation of soluble epoxide hydrolase and lipidomic profiles in anorexia nervosa. Mol Psychiatry 21:537-46|
|Kind, Tobias; Cho, Eunho; Park, Taeeun D et al. (2016) Interstitial Cystitis-Associated Urinary Metabolites Identified by Mass-Spectrometry Based Metabolomics Analysis. Sci Rep 6:39227|
|Fahrmann, Johannes F; Grapov, Dmitry; DeFelice, Brian C et al. (2016) Serum phosphatidylethanolamine levels distinguish benign from malignant solitary pulmonary nodules and represent a potential diagnostic biomarker for lung cancer. Cancer Biomark 16:609-17|
|Shahin, Mohamed H; Gong, Yan; McDonough, Caitrin W et al. (2016) A Genetic Response Score for Hydrochlorothiazide Use: Insights From Genomics and Metabolomics Integration. Hypertension 68:621-9|
|Chen, Zhaohui; Kim, Jayoung (2016) Urinary proteomics and metabolomics studies to monitor bladder health and urological diseases. BMC Urol 16:11|
|Zhao, Yan; Wan, Debin; Yang, Jun et al. (2016) Catalytic Activities of Tumor-Specific Human Cytochrome P450 CYP2W1 Toward Endogenous Substrates. Drug Metab Dispos 44:771-80|
|Fiehn, Oliver (2016) Metabolomics by Gas Chromatography-Mass Spectrometry: Combined Targeted and Untargeted Profiling. Curr Protoc Mol Biol 114:30.4.1-30.4.32|
|Fahrmann, Johannes F; Grapov, Dmitry; Phinney, Brett S et al. (2016) Proteomic profiling of lung adenocarcinoma indicates heightened DNA repair, antioxidant mechanisms and identifies LASP1 as a potential negative predictor of survival. Clin Proteomics 13:31|
Showing the most recent 10 out of 105 publications